ClinicalTrials.Veeva

Menu

ABVN Phase 2 - PENFS (ABVN2)

Indiana University logo

Indiana University

Status

Completed

Conditions

Healthy Subjects

Treatments

Device: Percutaneous Electrical Nerve Field Stimulation (PENFS)

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT07856446
1OT2OD028183-01 (U.S. NIH Grant/Contract)
2006075899-D

Details and patient eligibility

About

The vagus nerve is a nerve that controls many bodily functions, including stomach function. Investigators hope that electrically stimulating the nerve around the external ear will also stimulate the internal vagus nerve. If it does, then investigators hope that this may lead to additional treatment options for patients with nausea and vomiting and disordered stomach function.

The overall purpose of the ABVN Phase 2 grant is to expand on previous work evaluating the effects of noninvasive stimulation on vagal nerve function. This will be accomplished through several independent, but related, studies. In this study, investigators will evaluate the effect of percutaneous electrical field stimulation on the vagus nerve in healthy subjects.

[This study was originally described in NCT06491758, however a separate record has been created to more accurately reflect the independence of the individual studies supported by the ABVN 2 grant.]

Full description

Healthy volunteer subjects will be recruited for this project, which will be completed at a single study visit.

When participants arrive, they will be fitted with:

  • the PENFS device; placed behind the left ear using steri strips after the skin is cleansed using Sureprep (a medicinal wipe similar to an alcohol wipe)

  • Multi-electrode array (MEA); which consists of 30 small, plastic electrocardiogram (ECG) like electrodes that stick to the skin and will be placed on either side of the neck area over the vagus nerve.

  • ECG electrodes, placed on:

    • on the chest and arms or legs (for measurement of the ECG)
    • on the abdomen (to record the electrogastrogram, or EGG).

Participants will lie on their back and undergo a 20-minute baseline recording of vagal nerve activity. During the baseline recording, no current is delivered to the ear. Following the baseline recording, participants will undergo their randomly assigned experimental condition (either active stimulation delivered via the PENFS device, or no stimulation) for 20 minutes, After the experimental recording is completed, the device will be removed and participants will continue to lie on their back for 20 minutes of recovery.

Continuous vagal nerve, ECG, and EGG recordings are obtained during the baseline, experimental, and recovery rest periods.

Enrollment

23 patients

Sex

All

Ages

18 to 80 years old

Volunteers

Accepts Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria healthy volunteers

  • No gastrointestinal symptoms or conditions
  • Aged 18-80 years
  • Willing to have electrodes placed in the external ear
  • Willing to have MEA electrodes placed on the neck and bipolar electrodes placed on chest and stomach

Exclusion Criteria healthy volunteers:

  • Unable to provide consent
  • Having gastric motility issues (not due to COVID 19) as determined by the PI or Sub-I
  • Taking medications affecting gastric motility
  • Anyone using cardiac pacemakers
  • History of hemophilia
  • History of psoriasis
  • Allergy to Sureprep
  • Allergy to steri strip compound benzoin tincture
  • Skin behind the ear is not healthy or not intact
  • Pregnant females
  • Prisoners

Trial design

Primary purpose

Other

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

23 participants in 2 patient groups

Healthy Subjects - PENFS Stimulation
Active Comparator group
Description:
All participants will have the PENFS device placed, however, only participants randomized to active stimulation will have the device turned on for a period of 20 minutes (experimental phase).
Treatment:
Device: Percutaneous Electrical Nerve Field Stimulation (PENFS)
Healthy Subjects - No PENFS Stimulation
Sham Comparator group
Description:
All participants will have the PENFS device placed, however, the device will not be turned on during the experimental phase for participants randomized to sham stimulation.
Treatment:
Device: Percutaneous Electrical Nerve Field Stimulation (PENFS)

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems